TLGS services & expertise · Curated intelligence
Healthcare, Pharma & Life Sciences is a critical pillar of India's economy and social infrastructure, overseen by the Ministry of Health & Family Welfare, Ministry of Chemicals & Fertilizers (Pharma division), and NITI Aayog. India is the world's largest supplier of generic medicines, supplying over 20% of global generic drug exports, while domestic health infrastructure is being scaled through Ayushman Bharat and the National Health Mission. Policy direction focuses on universal health coverage, PLI-driven pharma manufacturing, and positioning India as a global hub for medical devices and biologics.
Bharat Pulse · Enterprise intelligence · 17 September 2026
Policy developments translated into commercial implications, decisions and practical next steps.
For large enterprises, rate changes, exemptions and process reform become material through credit treatment, contracts, master data and the quality of the compliance record.
Effective framework · further process-reform watch
Read the brief & business implications →Reviewed 17 September 2026Bharat Pulse · TLGS Research · 2026-09-15
Official-source facts and TLGS perspectives, separated by status. An announced project is not an open bid; consultancy fees are distinct from the value of the underlying project.
Prepared research edition. Advertised notices require current issuer, corrigendum and award-status checks. This is not an exhaustive live procurement feed or a statement that TLGS is retained on these projects.
Union Budget 2026–27 announced Biopharma SHAKTI with an outlay of ₹10,000 crore over five years.
Healthcare, Pharma & Life Sciences · Manufacturing, MSME & Industrial Policy · Education & Skills
Read the brief & official sources →CDSCO’s public-notice list carries a 5 September 2026 item on coordinated action against illegal manufacture and distribution of misbranded drugs.
Healthcare, Pharma & Life Sciences · Manufacturing, MSME & Industrial Policy · Governance & Admin
Read the brief & official sources →CDSCO’s register includes August 2026 pendency statements uploaded in early September, including a West Zone publication dated 8 September.
Healthcare, Pharma & Life Sciences · Manufacturing, MSME & Industrial Policy · Governance & Admin
Read the brief & official sources →UK guidance published on 4 September 2026 records that CETA entered into force on 15 July 2026. It also sets India’s graduation from the UK’s DCTS for 15 July 2028.
Trade, Customs & Strategic Supply Chains · Manufacturing, MSME & Industrial Policy · Healthcare, Pharma & Life Sciences · Agriculture, Food Processing & Rural Economy · Financial Services, Capital Markets & Insurance
Read the brief & official sources →EFTA records TEPA entering into force on 1 October 2025. The participating EFTA states are Iceland, Liechtenstein, Norway and Switzerland. Its investment-mobilisation objectives are long-term goals, not automatic funding entitlements.
Trade, Customs & Strategic Supply Chains · Manufacturing, MSME & Industrial Policy · Financial Services, Capital Markets & Insurance · Healthcare, Pharma & Life Sciences · Power, Energy & Renewables
Read the brief & official sources →The European Commission’s agreements page records conclusion of EU–India FTA negotiations on 27 January 2026. That statement alone does not establish entry into force.
Trade, Customs & Strategic Supply Chains · Manufacturing, MSME & Industrial Policy · Healthcare, Pharma & Life Sciences · Agriculture, Food Processing & Rural Economy · Financial Services, Capital Markets & Insurance
Read the brief & official sources →The third EU–India Trade and Technology Council update of 15 July 2026 covers cooperation in digital and clean technologies and the start of formal discussions on India’s association with Horizon Europe.
AI, Cybersecurity & Data Governance · Digital, Telecom & Electronics · Power, Energy & Renewables · Healthcare, Pharma & Life Sciences · Agriculture, Food Processing & Rural Economy · Trade, Customs & Strategic Supply Chains · Education & Skills
Read the brief & official sources →Engage TLGS
Connect the right expertise with your next decision.
